![]() ![]() Currently, there is only one FDA-approved DMT for primary-progressive MS, which has modest effect in slowing the disability accumulation over time. Therefore, it's best to develop a treatment regimen during the earlier relapsing-remitting phase.Ībout 10% of people with multiple sclerosis are diagnosed with a progressive form (primary-progressive MS) at the onset of the disease. ![]() Currently available DMTs have little impact on this phase of MS. Some people with relapsing-remitting MS can transition to secondary-progressive MS after several years.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |